Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1)

Journal of Biological Chemistry

Volumn 288, Issue 27, 2013, Pages 19581-19592

  Dai, Chao ^a   Shi, Dingding ^a   Gu, Wei ^a,b  

^a Columbia University College ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL TRANSFERASE; APOPTOTIC RESPONSE; ENDOGENOUS LEVEL; NEGATIVE REGULATORS; STRESS RESPONSE; TUMORIGENESIS; UBIQUITIN-LIKE; UBIQUITINATION;

CELL DEATH;

ACETYLATION;

ACYLTRANSFERASE; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PUMA PROTEIN; TIP60 PROTEIN; UBIQUITIN; UHRF1 PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA INTERFERENCE; UBIQUITINATION;

ACETYLATION; APOPTOSIS; GROWTH ARREST; ONCOGENE; P53; TIP60; TUMOR SUPPRESSOR GENE; UBIQUITINATION; UHRF1;

ACETYLATION; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONE ACETYLTRANSFERASES; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84880049953     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.476606     Document Type: Article

References (58)

1. Vousden, K. H., and Prives, C. (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137, 413-431
2. Kruse, J. P., and Gu, W. (2009) Modes of p53 regulation. Cell 137, 609-622
3. Dai, C., and Gu, W. (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol. Med. 16, 528-536
4. Tang, Y., Zhao, W., Chen, Y., Zhao, Y., and Gu, W. (2008) Acetylation is indispensable for p53 activation. Cell 133, 612-626
5. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006) Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839
6. Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., and McMahon, S. B. (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell 24, 841-851
7. Gaughan, L., Logan, I. R., Cook, S., Neal, D. E., and Robson, C. N. (2002) Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J. Biol. Chem. 277, 25904-25913
8. Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. M., Livingston, D. M., and Amati, B. (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4, 575-580
9. Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C. J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., Blobel, G. A., and McMahon, S. B. (2004) The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell Biol. 24, 10826-10834
10. Yamamoto, T., and Horikoshi, M. (1997) Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J. Biol. Chem. 272, 30595-30598
11. Sun, Y., Jiang, X., Chen, S., Fernandes, N., and Price, B. D. (2005) A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U.S.A. 102, 13182-13187
12. Kusch, T., Florens, L., Macdonald, W. H., Swanson, S. K., Glaser, R. L., Yates, J. R., 3rd, Abmayr, S. M., Washburn, M. P., and Workman, J. L. (2004) Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306, 2084-2087
13. Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B., Agami, R., Ge, W., Cavet, G., Linsley, P. S., Beijersbergen, R. L., and Bernards, R. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437
14. Ma, H., Chen, H., Guo, X., Wang, Z., Sowa, M. E., Zheng, L., Hu, S., Zeng, P., Guo, R., Diao, J., Lan, F., Harper, J. W., Shi, Y. G., Xu, Y., and Shi, Y. (2012) M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc. Natl. Acad. Sci. U.S.A. 109, 4828-4833
15. Kim, J. K., Estève, P. O., Jacobsen, S. E., and Pradhan, S. (2009) UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res. 37, 493-505
16. Achour, M., Fuhrmann, G., Alhosin, M., Rondé, P., Chataigneau, T., Mousli, M., Schini-Kerth, V. B., and Bronner, C. (2009) UHRF1 recruits the histone acetyltransferase Tip60 and controls its expression and activity. Biochem. Biophys. Res. Commun. 390, 523-528
17. Du, Z., Song, J., Wang, Y., Zhao, Y., Guda, K., Yang, S., Kao, H. Y., Xu, Y., Willis, J., Markowitz, S. D., Sedwick, D., Ewing, R. M., and Wang, Z. (2010) DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal 3, ra80
18. Unoki, M. (2011) Current and potential anticancer drugs targeting members of the UHRF1 complex including epigenetic modifiers. Recent Patents on Anti-cancer Drug Discovery 6, 116-130
19. Fujimori, A., Matsuda, Y., Takemoto, Y., Hashimoto, Y., Kubo, E., Araki, R., Fukumura, R., Mita, K., Tatsumi, K., and Muto, M. (1998) Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation. Mamm. Genome 9, 1032-1035
20. Hopfner, R., Mousli, M., Jeltsch, J. M., Voulgaris, A., Lutz, Y., Marin, C., Bellocq, J. P., Oudet, P., and Bronner, C. (2000) ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIα expression. Cancer Res. 60, 121-128
21. Mousli, M., Hopfner, R., Abbady, A. Q., Monté, D., Jeanblanc, M., Oudet, P., Louis, B., and Bronner, C. (2003) ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br. J. Cancer 89, 120-127
22. Unoki, M., Nishidate, T., and Nakamura, Y. (2004) ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23, 7601-7610
23. Crnogorac-Jurcevic, T., Gangeswaran, R., Bhakta, V., Capurso, G., Lattimore, S., Akada, M., Sunamura, M., Prime, W., Campbell, F., Brentnall, T. A., Costello, E., Neoptolemos, J., and Lemoine, N. R. (2005) Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129, 1454-1463
24. Oba-Shinjo, S. M., Bengtson, M. H., Winnischofer, S. M., Colin, C., Vedoy, C. G., de Mendonça, Z., Marie, S. K., and Sogayar, M. C. (2005) Identification of novel differentially expressed genes in human astrocytomas by cDNArepresentational difference analysis. Brain Res. Mol. Brain Res. 140, 25-33
25. Jenkins, Y., Markovtsov, V., Lang, W., Sharma, P., Pearsall, D., Warner, J., Franci, C., Huang, B., Huang, J., Yam, G. C., Vistan, J. P., Pali, E., Vialard, J., Janicot, M., Lorens, J. B., Payan, D. G., and Hitoshi, Y. (2005) Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol. Biol. Cell 16, 5621-5629
26. Unoki, M., Kelly, J. D., Neal, D. E., Ponder, B. A., Nakamura, Y., and Hamamoto, R. (2009) UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br. J. Cancer 101, 98-105
27. Lorenzato, M., Caudroy, S., Bronner, C., Evrard, G., Simon, M., Durlach, A., Birembaut, P., and Clavel, C. (2005) Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum. Pathol. 36, 1101-1107
28. Kofunato, Y., Kumamoto, K., Saitou, K., Hayase, S., Okayama, H., Miyamoto, K., Sato, Y., Katakura, K., Nakamura, I., Ohki, S., Koyama, Y., Unoki, M., and Takenoshita, S. (2012) UHRF1 expression is upregulated and associated with cellular proliferation in colorectal cancer. Oncol. Rep 28, 1997-2002
29. Rajakumara, E., Wang, Z., Ma, H., Hu, L., Chen, H., Lin, Y., Guo, R., Wu, F., Li, H., Lan, F., Shi, Y. G., Xu, Y., Patel, D. J., and Shi, Y. (2011) PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol. Cell 43, 275-284
30. Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., and Shirakawa, M. (2008) Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 455, 818-821
31. Hashimoto, H., Horton, J. R., Zhang, X., Bostick, M., Jacobsen, S. E., and Cheng, X. (2008) The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455, 826-829
32. Avvakumov, G. V., Walker, J. R., Xue, S., Li, Y., Duan, S., Bronner, C., Arrowsmith, C. H., and Dhe-Paganon, S. (2008) Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 455, 822-825
33. Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T. A., Shinga, J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., Tajima, S., Mitsuya, K., Okano, M., and Koseki, H. (2007) The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912
34. Karagianni, P., Amazit, L., Qin, J., and Wong, J. (2008) ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol. Cell. Biol. 28, 705-717
35. Citterio, E., Papait, R., Nicassio, F., Vecchi, M., Gomiero, P., Mantovani, R., Di Fiore, P. P., and Bonapace, I. M. (2004) Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol. Cell. Biol. 24, 2526-2535
36. Guan, D., Factor, D., Liu, Y., Wang, Z., and Kao, H. Y. (2012) The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein. Oncogene
37. Babbio, F., Pistore, C., Curti, L., Castiglioni, I., Kunderfranco, P., Brino, L., Oudet, P., Seiler, R., Thalman, G. N., Roggero, E., Sarti, M., Pinton, S., Mello-Grand, M., Chiorino, G., Catapano, C. V., Carbone, G. M., and Bonapace, I. M. (2012) The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 31, 4878-4887
38. Sabatino, L., Fucci, A., Pancione, M., Carafa, V., Nebbioso, A., Pistore, C., Babbio, F., Votino, C., Laudanna, C., Ceccarelli, M., Altucci, L., Bonapace, I. M., and Colantuoni, V. (2012) UHRF1 coordinates peroxisome proliferator activated receptor γ (PPARG) epigenetic silencing and mediates colorectal cancer progression. Oncogene 31, 5061-5072
39. Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263-269
40. Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S., Confalonieri, S., Cesaroni, M., Marchesi, F., Gasco, M., Scanziani, E., Capra, M., Mai, S., Nuciforo, P., Crook, T., Lough, J., and Amati, B. (2007) Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 448, 1063-1067
41. Charvet, C., Wissler, M., Brauns-Schubert, P., Wang, S. J., Tang, Y., Sigloch, F. C., Mellert, H., Brandenburg, M., Lindner, S. E., Breit, B., Green, D. R., McMahon, S. B., Borner, C., Gu, W., and Maurer, U. (2011) Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 42, 584-596
42. Wang, J., and Chen, J. (2010) SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60. J. Biol. Chem. 285, 11458-11464
43. Legube, G., Linares, L. K., Lemercier, C., Scheffner, M., Khochbin, S., and Trouche, D. (2002) Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 21, 1704-1712
44. Bhoumik, A., Singha, N., O'Connell, M. J., and Ronai, Z. A. (2008) Regulation of TIP60 by ATF2 modulates ATM activation. J. Biol. Chem. 283, 17605-17614
45. Creaven, M., Hans, F., Mutskov, V., Col, E., Caron, C., Dimitrov, S., and Khochbin, S. (1999) Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 38, 8826-8830
46. Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T., and Dutta, A. (2010) Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway. Mol Cell 38, 700-711
47. Gupta, A., Jha, S., Engel, D. A., Ornelles, D. A., and Dutta, A. (2012) Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene, DOI 10.1038/onc.2012.534. [Epub ahead of print]
48. Dai, C., Tang, Y., Jung, S. Y., Qin, J., Aaronson, S. A., and Gu, W. (2011) Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc. Natl. Acad. Sci. U.S.A. 108, 18937-18942
49. Ikeda, F., and Dikic, I. (2008) Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 9, 536-542
50. Batty, N., Malouf, G. G., and Issa, J. P. (2009) Histone deacetylase inhibitors as anti-neoplastic agents. Cancer Lett. 280, 192-200
51. Witt, O., and Lindemann, R. (2009) HDAC inhibitors: magic bullets, dirty drugs or just another targeted therapy. Cancer Lett. 280, 123-124
52. Weichert, W. (2009) HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 280, 168-176
53. Etoh, T., Kanai, Y., Ushijima, S., Nakagawa, T., Nakanishi, Y., Sasako, M., Kitano, S., and Hirohashi, S. (2004) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164, 689-699
54. Peng, D. F., Kanai, Y., Sawada, M., Ushijima, S., Hiraoka, N., Kosuge, T., and Hirohashi, S. (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 96, 403-408
55. Sawada, M., Kanai, Y., Arai, E., Ushijima, S., Ojima, H., and Hirohashi, S. (2007) Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion. Cancer Lett. 251, 211-219
56. Witt, O., Deubzer, H. E., Milde, T., and Oehme, I. (2009) HDAC family: What are the cancer relevant targets? Cancer Lett. 277, 8-21
57. Bronner, C., Achour, M., Arima, Y., Chataigneau, T., Saya, H., and Schini-Kerth, V. B. (2007) The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol. Ther. 115, 419-434
58. Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., and Gu, W. (2003) Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975